Symptom perception in relation to hormonal status in female fibromyalgia syndrome patients

Journal of Musculoskeletal Pain

Volumn 7, Issue 3, 1999, Pages 21-38

  Anderberg, Ulla Maria ^a   Marteinsdottir, Ina ^a   Hallman, Jarmila ^a   Ekselius, Lisa ^a   Bäckström, Torbjörn ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Fibromyalgia; Hormonal state; Pain; Stress; Symptoms

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; FIBROMYALGIA; HUMAN; NOCICEPTION; PAIN ASSESSMENT; PAIN THRESHOLD; POSTMENOPAUSE; PREMENOPAUSE; PSYCHOLOGICAL ASPECT; SOCIAL ASPECT; SYMPTOMATOLOGY; WELLBEING;

EID: 0032835685     PISSN: 10582452     EISSN: None     Source Type: Journal    
DOI: 10.1300/J094v07n03_03     Document Type: Article

References (62)

1. Bennett RM: Beyond fibromyalgia: Ideas on etiology and management. J Rheumatol (suppl 19) 16: 131-136, 1989.
2. Bengtsson A, Henriksson KG: The muscle in fibromyalgia-a review of Swedish studies. J Rheumatol (suppl 19) 16: 144-149, 1989.
3. Henriksson KG, Mense S: Pain and nociception in fibromyalgia: clinical and neurobiological considerations on etiology and pathogenesis. Pain Reviews 1: 245-260, 1994.
4. Walker EA, Keegan D, Gardner G, Sullivan M, Katon WJ, Bernstein D: Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: I. Psychiatric diagnosis and functional disability. Psychosomatic Medicine 59: 565-571, 1997.
5. Walker EA, Keegan D, Gardner G, Sullivan M, Bernstein D, Katon WJ: Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: II. Sexual, physical, and emotional abuse and neglect. Psychosomatic Medicine 59: 572-579, 1997.
6. Yunus MB: Diagnosis, etiology and management of fibromyalgia syndrome: an update. Comprehen Ther 14: 8-20, 1988.
7. Yunus MB: Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation. J Rheumatol 19(6): 846-850, 1992.
8. Russell IJ: Neurohormonal aspects of fibromyalgia syndrome. Rheum Dis Clin N Am 15: 149-168, 1989.
9. Russell IJ, Vaeroy H, Javors M, Nyberg F: Cerebrospinal fluid of biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 35(5): 550-556, 1992.
10. Russell IJ: Neurohormonal: Abnormal laboratory findings related to pain and fatigue in fibromyalgia. J Musculoske Pain 3(2): 59-65, 1995.
11. Vaeroy H, Helle R, Forre O, et al: Elevated CSF levels of substance P and high incidence of Raynaud's phenomen in patients with fibromyalgia: New features for diagnosis. Pain 32: 21-26, 1988.
12. Liu Z, Welin M, Brageé B, Thörnwall M, Nyberg F: Elevated substance P levels in cerebrospinal fluid from patients with fibromyalgia is contrasted by a decrease in Met-Enkephalin-Arg-Phe. Analgesia 1: 543-547, 1995.
13. Griep EN, Boersma JW, de Koet ER: Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 20(3): 469-474, 1993.
14. Crofford LJ, Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA, Sternberg EM, Gold PW, Chrousos GP, Wilder RL: Hypothalamic-pituitary-adrenal axis in patients with fibromyalgia. Arthritis Rheum 37: 1583-1592, 1994.
15. Crofford LJ: The Hypothalamic-Pituitary-Adrenal Stress Axis in the Fibromyalgia syndrome. J Musculoske Pain 4(1/2): 181-200, 1996.
16. Waxman J, McSherry Zatkis S: Fibromyalgia and menopause. Postgraduate Medicine 80(4): 165-171, 1986.
17. Carette S, Dessureault M, Belanger A: Fibromyalgia and sex hormones. J Rheumatol (letter) 19(5): 831, 1992.
18. Ostensen M, Rugelsjoen A, Wigers SH: The effect of reproductive events and alterations of sex hormone levels on the symptoms of fibromyalgia. Scand J Rheumatol 26(5): 355-360, 1997.
19. Anderberg UM, Marteinsdottir I, Hallman J, Bäckström T: Variability in cyclicity affects pain and other symptoms in female fibromyalgia syndrome. J Musculoske Pain 6(4): 5-22, 1998.
20. Bäckström T: Central nervous system effects, mood and cognitive function related to menopause and hormone replacement therapy. In: The climacteric and its treatment. Eds. Sjöberg NO, Berg G, Hammar M, Mattson LÅ. SCOGS, the Swedish Consensus of Obstetrics and Gynecology Series, pp 75-86, 1997.
21. Bäckström T, Baird DT, Bancroft J, Bixo M, Hammarbäck S, Sanders D, Smith S, Zetterlund B: Endocrinological aspects of cyclical mood changes during the menstrual cycle or the premenstrual syndrome. J Psychosom Obstet Gynaecol 2: 8-20, 1983.
22. Halbreich U: Gonadal hormones and antihormones, serotonin and mood. Psychopharm Bull 26: 291-295, 1990.
23. Guicheney P, Marcel D: Decrease of platelet serotonin content in ovariectomized female rats. Endocrinology 111(6): 2412-2414, 1984.
24. Biegon A, Fischette CT, Rainbow TC, McEwen BS: Serotonin receptor modulation by estrogen in discrete brain nuclei. Neuroendocrinology 35: 287-291, 1982.
25. Kendall D, Stancel GM, Enna SJ: Imipramine: Effect of ovarian steroids on modifications in serotonin-receptor binding. Science 211: 1183-1185, 1981.
26. Rehavi M, Sepcuti H, Weizman A: Upregulation by imipramin-binding and serotoninuptake by estradiol in female rat brain. Brain Research 410: 135-139, 1987.
27. Crowley WR, O'Donohue TL, Muth EA, Jacobowitz DM: Effects of ovarian hormones on levels of luteinizing hormone in plasma and on serotonin concentrations in discrete brain nuclei. Brain Research Bulletin 4: 571-574, 1979.
28. Cone RI, Davis GA, Goy RW: Effects of ovarian steroids on serotonin metabolism within grossly dissected and microdissected brain regions of the ovariectomized rat. Brain Research Bulletin 7: 639-644, 1981.
29. Rapkin AJ, Shoupe D, Reading A, Daneshgar KK, Goldman L, Bohn Y, Brann DW, Mahesh VB: Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone. J Soc Gynecol Invest 3(2): 93-98, 1996.
30. Shoupe D, Montz FJ, Lobo RA: The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women. J Clin Endocrinol Metab 60: 178-183, 1985.
31. Wardlaw SL, Wehrenberg WB, Ferin M, Antunes JL, Frantz AG: Effect of sex steroids on B-endorphin in hypophyseal portal blood. J Clin Endocrinol Metab 55: 877-888, 1982.
32. Chrousos GP, Gold PW: The concepts of stress and stress system disorders. JAMA 267(9): 1244-1252, 1992.
33. Bixo M, Bäckström T, Winblad B, Andersson A: Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J Steroid Biochem Molec Biol 55: 297-303, 1995.
34. Barfield RJ, Glaser YH, Rubin BS, Eigen AM. Behavioral effects of progestin in the brain. Psychoneuroendocrinology 9: 217-231, 1984.
35. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fichtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP: The American College of Rheumatology 1990 criteria for the classification of Fibromyalgia. Arthritis Rheum 33: 160-172, 1990.
36. Kosek E, Ekholm J: Modulation of pressure pain thresholds during and following isometric contraction. Pain 61: 481-486, 1995.
37. Svanborg P, Åsberg M: A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale. Acta Psychiatr Scand 89: 21-28, 1994.
38. Beck AT, Beamesderfer A: Assessment of depression: The Depression Inventory. Psychological Measurements in Psychopharmacology. Mod Probl Pharmacopsychiatr, vol 7, pp 151-169, ed. P Pichot, Paris (Karger, Basel 1974).
39. Diagnostic and Statistical Manual of Mental Disorders, 4th edition. American Psychiatric Association. Washington, DC 20005, USA, 1994, pp 715-718.
40. Conover WJ. In: Practical nonparametric statistics, second edition, John Wiley and sons (Eds), New York, 1980.
41. Tukey JW: Exploratory data analysis. Massachusetts, Addison-Wesley, 1977.
42. Ladisich W: Influence of progesterone on serotonin metabolism: a possible causal factor for mood changes. Psychoneuroendocrinology 2: 257-266, 1977.
43. Biegon A: Effects of steroid hormones on the serotonergic system. Ann NY Acad Sci 600: 427-434, 1990.
44. Hunter MS: The S.E. England longitudinal study of the climacteric and post-menopause. Maturitas 14: 117-126, 1992.
45. Kaufert PA, Gilbert P, Tate R: The Manitoba Project; a re-examination of the relationship between menopause and depression. Maturitas 14: 143-156, 1992.
46. McKinley JB, McKinley SM, Brambilla D: The relative contributions of endocrine changes and social circumstances to depression and mid-aged women. Journal of Health and Social Behavior 28: 345-363, 1987.
47. Ballinger CB: Psychiatric aspects of the menopause. Br J Psychiatry 156: 773-787, 1990.
48. Dennerstein L, Smith AM, Morse C, Burger H, Green A, Hopper J, Ryan M: Menopausal symptoms in Australian women. Med J Aust 159: 232-236, 1993.
49. Collins A, Landgren BM: Reproductive health, use of estrogen and experience of symptoms in perimenopausal women: a population-based study. Maturitas 20: 101-111, 1995.
50. Sherwin BB, Gelfand MM: Sex steroids and affect in the surgical menopause: a double-blind and cross-over study. Psychoneuroendocrinology 10: 325-335, 1985.
51. Montgomery JC, Appleby L, Brincat M et al: Effect of estrogen and testosterone implants on psychological disorders in the climacteric. Lancet 7: 297-299, 1987.
52. Dennerstein L, Burrows GD, Hyman GJ, Sharpe K: Hormone therapy and affect. Maturitas 1: 247-259, 1979.
53. Ditcoff EJ, Crary WG, Cristo M, Lobo RA: Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 78: 991-995, 1991.
54. Bäckström T, Sanders D, Leask R, Davidson D, Warner P, Bancroft J: Mood, sexuality, hormones and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome 45: 503-507, 1983.
55. Gitlin MJ, Pasnau RO: Psychiatric syndromes linked to reproductive function in women: a review of current knowledge. Am J Psychiatr 146: 1413-1422, 1989.
56. Utian WH: Menopause, hormone therapy and quality of life. Prog Clin Biol Res 320: 193-209, 1990.
57. von Knorring L, Perris C, Eisemann M, Ericsson U, Perris H: Pain as a symptom in depressive disorders. I. Relationship to a diagnostic subgroup and depressive symptomatology. Pain 15: 19-26, 1983.
58. von Knorring L, Ekselius L: Idiopathic pain and depression. Quality of Life Research 3: 57-68, 1994.
59. Matthews KA, Berga SL, Owens JF, Flory JD: Effects of short-term suppression of ovarian hormones on cardiovascular and neuroendocrine reactivity to stress in women. Psychoneuroendocrinology 23(4): 307-322, 1998.
60. Ekselius L, Bengtsson A: Personality trails as determined by means of the Karolinska Scales of Personality in patients with fibromyalgia. J Musculoske Pain 6(2): 35-49, 1998.
61. Anderberg UM, Forsgren T, Ekselius L, Marteinsdottir I, Hallman J: Personality traits according to the Temperament and Character Inventory (TCI) in fibromyalgia syndrome patients. Nordic J Psychiatry (in press).
62. White KP, Nielsson WR: Cognitive behavioral treatment of fibromyalgia syndrome: a follow-up assessment. J Rheumatol 22: 717-721, 1995.